Author: Liegeois J.-F. Bruhwyler J. Damas J. Rogister F. Masereel B. Geczy J. Delarge J.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.273, Iss.3, 1995-02, pp. : 1-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Kohn Y. Ebstein R.P. Heresco-Levy U. Shapira B. Nemanov L. Gritsenko I. Avnon M. Lerer B.
European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. :
By Schlachter S.K. Poel T.J. Lawson C.F. Dinh D.M. Lajiness M.E. Romero A.G. Rees S.A. Duncan J.N. Smith M.W.
European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. :
Further evidence for clozapine as a dopamine D 1 receptor agonist
European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. :
By Abekawa T. Ito K. Koyama T.
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 3, 2006-12 ,pp. :